Loading...
•
Mar 31, 2022
Beauty Health Q1 2022 Earnings Report
BeautyHealth delivered strong growth, driven by robust demand and the successful launch of Syndeo, leading to increased full-year guidance.
Key Takeaways
BeautyHealth reported a strong first quarter with net sales increasing by 58.6% to $75.4 million. The company raised its full-year net sales guidance to $330-340 million, reflecting confidence in its growth plan.
Net sales increased by 58.6% to $75.4 million compared to Q1 2021.
Delivery Systems net sales increased to $41.6 million, driven by the successful launch of Syndeo.
Consumables net sales increased to $33.8 million, reflecting continued strong demand.
The company increased its full-year net sales guidance to $330.0 million - $340.0 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
BeautyHealth increased its fiscal 2022 guidance and now expects net sales in the range of $330.0 million to $340.0 million, up from the previous outlook for $320.0 million to $330.0 million. The Company also reaffirmed its outlook for adjusted EBITDA of approximately $50.0 million.
Positive Outlook
- Increased full-year net sales guidance to $330.0 million - $340.0 million.
- Reaffirmed outlook for adjusted EBITDA of approximately $50.0 million.
- Reflects management's confidence in the business.
- Company executes against its growth plan.
- Momentum in health and wellness.
Challenges Ahead
- Assumes no material deterioration in general market conditions.
- Assumes no material deterioration or other factors related to COVID-19 trends.
- Cautious of the potential risk for further market closures or other restrictive measures from existing or new COVID-19 strains.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...